0:00
43:41
This week, we take a look at the latest in the U.N. secretary-general race. In the latest informal straw poll to gauge support for the next U.N. secretary-general, Costa Rican diplomat Rebeca Grynspan secured the nine Security Council votes needed to advance but faced opposition from two permanent members — meaning the threat of a veto remains. The race is far from over, as new candidates can still enter at any point in the process. We also contemplate what kind of secretary-general the Trump administration would want and support.
During the conversation, we also discussed the speech of the U.K.’s foreign secretary, Ed Miliband, at the World Bank-IMF annual meetings in Bangkok. Miliband outlined key commitments ahead of the U.K.’s presidency of the Group of 20 leading economies next year, including tackling debt and the illicit financial flows that hinder tax collection in the global south.
What would happen if a U.N. secretary-general is not picked before António Guterres’ term expires? And is addressing debt back on the development agenda?
To answer these questions and to dig into these stories, Devex Business Editor David Ainsworth sits down with Managing Editor Anna Gawel and Senior Global Reporter Colum Lynch for the latest episode of our weekly podcast series.
The threat of antimalarial drug resistance is growing in Eastern and Southern Africa, where the malaria parasite is rapidly adapting to existing treatments. With WHO modeling showing that a full-blown resistance crisis could lead to nearly 16 million additional cases and 80,000 deaths annually, Dr. Martin Fitchet of Medicines for Malaria Venture and Joy Phumaphi of the African Leaders Malaria Alliance sit down with Devex’s Alan Robbins to discuss why proactive R&D funding must be treated as an immediate global health priority.
This spotlight segment presented in partnership with Medicines for Malaria Venture explores next-generation pipeline solutions, including the novel candidate ganaplacide-lumefantrine, single-dose cures, and long-acting seasonal preventatives capable of protecting communities with a single shot. Shifting from reactive crisis response to sustained investment in medical innovation and health infrastructure, both leaders urge global partners and heads of state to act now to prevent a potentially catastrophic resurgence.
During the conversation, we also discussed the speech of the U.K.’s foreign secretary, Ed Miliband, at the World Bank-IMF annual meetings in Bangkok. Miliband outlined key commitments ahead of the U.K.’s presidency of the Group of 20 leading economies next year, including tackling debt and the illicit financial flows that hinder tax collection in the global south.
What would happen if a U.N. secretary-general is not picked before António Guterres’ term expires? And is addressing debt back on the development agenda?
To answer these questions and to dig into these stories, Devex Business Editor David Ainsworth sits down with Managing Editor Anna Gawel and Senior Global Reporter Colum Lynch for the latest episode of our weekly podcast series.
The threat of antimalarial drug resistance is growing in Eastern and Southern Africa, where the malaria parasite is rapidly adapting to existing treatments. With WHO modeling showing that a full-blown resistance crisis could lead to nearly 16 million additional cases and 80,000 deaths annually, Dr. Martin Fitchet of Medicines for Malaria Venture and Joy Phumaphi of the African Leaders Malaria Alliance sit down with Devex’s Alan Robbins to discuss why proactive R&D funding must be treated as an immediate global health priority.
This spotlight segment presented in partnership with Medicines for Malaria Venture explores next-generation pipeline solutions, including the novel candidate ganaplacide-lumefantrine, single-dose cures, and long-acting seasonal preventatives capable of protecting communities with a single shot. Shifting from reactive crisis response to sustained investment in medical innovation and health infrastructure, both leaders urge global partners and heads of state to act now to prevent a potentially catastrophic resurgence.
Mais episódios de "This Week in Global Development"
Não percas um episódio de “This Week in Global Development” e subscrevê-lo na aplicação GetPodcast.
